Compare GEMI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEMI | AMPH |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2005 |
| Metric | GEMI | AMPH |
|---|---|---|
| Price | $8.64 | $19.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $14.50 | ★ $30.29 |
| AVG Volume (30 Days) | ★ 1.5M | 499.1K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $21.99 | $7.34 |
| Revenue Next Year | $76.08 | $4.81 |
| P/E Ratio | ★ N/A | $9.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.57 | $18.94 |
| 52 Week High | $34.67 | $31.26 |
| Indicator | GEMI | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 57.93 | 24.36 |
| Support Level | $5.57 | N/A |
| Resistance Level | $11.29 | $28.56 |
| Average True Range (ATR) | 0.63 | 1.19 |
| MACD | 0.46 | -0.88 |
| Stochastic Oscillator | 73.67 | 4.31 |
Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.